Financials
Financial year 2025
Worth noting
- A loss two years in a row.
- Little cash and receivables against the short-term debts.
- Figures corrected afterwards (2022).
Gross margin
€ -168,161
▲ 60% vs 2024
Profit
Caution€ -390,094
▲ 34% vs 2024
Debts
Normal€ 1 million
▼ 39% vs 2024
COLE PHARMACEUTICALS from Mont-Saint-Guibert, company number BE0671904152, closed financial year 2025 with a result of € -390,094 after tax. For that financial year COLE PHARMACEUTICALS recorded a gross margin of € -168,161 and equity of € 468,254. Compared with financial year 2024, the result moved from € -592,788 to € -390,094. The company made a loss. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 26, 2026.
What happened at COLE PHARMACEUTICALS?
What happened at COLE PHARMACEUTICALS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 390,094. filed late Source: NBB ↗
- GUILLAUME DE VIRON stepped down as director. NBB
- GUILLAUME DE VIRON became a director. NBB
- JEAN-MARIE VANDEPLAS became a director. NBB
- CLAUDE LUBICKI became a director. NBB
- New establishment in Mont-Saint-Guibert. KBO
- Start of the company according to the CBE. KBO
In short
From € 651,525 loss in 2021 to € 390,094 loss in 2025.
A new publication or filing at COLE PHARMACEUTICALS? We notify you, reason included.
Follow COLE PHARMACEUTICALSNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind COLE PHARMACEUTICALS are JEAN-MARIE VANDEPLAS and CLAUDE LUBICKI. The same people are also behind MEDICAL MARKETING CONCEPT and BIOEXPAND.
Directors
According to the 2025 annual accounts
since 2019
since 2019
since 2020 · until 2023
Establishments
Establishment units
Physical locations of this company
Rue André Dumont 7
1435 Mont-Saint-Guibert
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
Details
- Company number
- 0671.904.152
- VAT number
- BE 0671.904.152
- Registered office
- Rue André Dumont 7, 1435 Mont-Saint-Guibert
- Names & denominations
- COLE PHARMACEUTICALS · Cole Pharma
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 28 February 2017
- Peppol
- Active · Active since 2 Dec 2025
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Handelsbemiddeling in meubelen, huishoudelijke artikelen en ijzerwaren